One of the challenges in prophylactic administration of G-CSF during chemotherapy is that it must be administered 24 h after dispensing chemotherapeutic drugs to achieve adequate prophylactic protection from neutropenia. This evidence concerns the gene CSF3 and Decreased total neutrophil count.